New Jersey vs Oklahoma on USAspending: $8.1B vs $5.5B

Twenty-three awards in New Jersey for each Oklahoma award

These figures are USAspending.gov obligations, not Treasury outlays. New Jersey’s $8.1B stock sits $2.6 billion above Oklahoma’s $5.5B. Place of performance in the award file is the scoring rule. New Jersey has more people (9,500,851 versus 4,095,393) and a vastly busier file. Oklahoma still posts the higher per-capita reading.

New Jersey’s $8,084,032,234 is spread across 1,162,765 records. Oklahoma’s $5,456,947,205 sits on 50,460. That is about 23 New Jersey awards for each Oklahoma award. Dollars favor New Jersey; paperwork volume favors New Jersey as well. Intensity and typical booking size do not.

New Jersey’s 1,162,765 awards versus Oklahoma’s 50,460 awards is a 23-to-1 paperwork gulf on $8,084,032,234 versus $5,456,947,205. FY2026 of $878,702,039 versus $843,573,742 is almost even. People of 9,500,851 versus 4,095,393 produce $92.49 versus $205.98. Pharmaceuticals versus aircraft parts is mix. A near-tied latest year should not be read as a stacked tie or a paperwork tie.

Oklahoma’s $205.98 versus New Jersey’s $92.49

New Jersey’s 9,500,851 residents against $8.1B produce $92.49 per capita. Oklahoma’s 4,095,393 residents against $5.5B produce $205.98. Intensity in Oklahoma is more than double New Jersey’s even though New Jersey holds the larger stacked total and the million-row file.

A $205.98 per-person reading is an intensity fact attached to $5.5B, not a household check. New Jersey’s $92.49 is attached to $8.1B. This table scores USAspending place of performance, not GDP. A 50,460-award file on $5.5B is consistent with a heavier typical booking than a 1,162,765-award file on $8.1B.

Pharmaceuticals in New Jersey, aircraft parts in Oklahoma

New Jersey’s top industry is pharmaceutical preparation manufacturing. Oklahoma’s is other aircraft parts and auxiliary equipment manufacturing. Those NAICS labels mark the largest grouping in each state’s file. Drug-manufacturing awards and aircraft-parts awards are different lead products sitting on $8.1B and $5.5B stocks.

A pharmaceutical-preparation lead inside New Jersey’s 1,162,765-award file can sit among many smaller actions. An aircraft-parts lead inside Oklahoma’s 50,460-award file can concentrate auxiliary equipment without making Oklahoma a single-product state. Mix and scale both differ. Neither label is the entire stock.

FY2026 nearly even: $878.7M vs $843.6M

FY2026 obligations are $878,702,039 in New Jersey and $843,573,742 in Oklahoma. New Jersey is slightly ahead in the latest year, on a stacked ranking that favors New Jersey by $2.6 billion. Recency questions belong in FY2026. The $8.1B and $5.5B totals remain the full USAspending.gov aggregate this comparison uses. Both years are obligations, not outlays.

Do not divide those FY figures by New Jersey’s 1,162,765 or Oklahoma’s 50,460 all-years awards. Per capita of $92.49 on 9,500,851 residents versus $205.98 on 4,095,393 residents is the intensity comparison. FY2026 is the cut that is nearly tied. Stacked totals still favor New Jersey.

New Jersey’s $878,702,039 FY2026 versus Oklahoma’s $843,573,742 is a recency near-tie on stocks of $8,084,032,234 versus $5,456,947,205. 1,162,765 awards versus 50,460 awards remain the paperwork gulf. 9,500,851 residents versus 4,095,393 residents produce $92.49 versus $205.98. A near-tied latest year is not a stacked tie. Both cuts are obligations.

A row gulf with a recency near-tie

New Jersey leads stacked dollars ($8.1B vs $5.5B), award count (1,162,765 vs 50,460), population (9,500,851 vs 4,095,393), and FY2026 by a thin margin ($878.7M vs $843.6M). Oklahoma leads per capita ($205.98 vs $92.49). The distinctive facts are the 23-to-1 row gap and the near-tied latest year.

Pharmaceutical preparation manufacturing versus other aircraft parts and auxiliary equipment manufacturing is mix inside files that contain many other industries. Use the New Jersey and Oklahoma hubs for agencies and recipients. Keep both stocks labeled as USAspending.gov obligations.

A 23-to-1 row gap with a near-tied latest year

New Jersey’s 1,162,765 awards on $8,084,032,234 versus Oklahoma’s 50,460 awards on $5,456,947,205 is the paperwork gulf. FY2026 of $878,702,039 versus $843,573,742 is almost even. Per capita of $92.49 on 9,500,851 residents versus $205.98 on 4,095,393 residents is the intensity inversion. Those three cuts should not be collapsed into one ranking.

Pharmaceutical preparation manufacturing versus other aircraft parts and auxiliary equipment manufacturing is mix. A million-row file and a 50,460-row file can sit on stocks in the same few-billion band. Both figures are USAspending.gov obligations by place of performance, not outlays.

Questions

Which state has more federal spending, New Jersey or Oklahoma?

New Jersey leads in stacked USAspending.gov obligations: $8,084,032,234 versus Oklahoma’s $5,456,947,205. New Jersey has far more awards (1,162,765 vs 50,460) and more people (9,500,851 vs 4,095,393). Spending per capita is $92.49 in New Jersey and $205.98 in Oklahoma. FY2026 obligations are $878.7M and $843.6M. These are obligations, not Treasury outlays.

Why does New Jersey have so many more awards than Oklahoma?

New Jersey logs 1,162,765 awards on $8.1B. Oklahoma logs 50,460 awards on $5.5B. New Jersey’s file is busier in rows on a larger stock, which implies a smaller typical booking. Per capita is $92.49 versus $205.98. Populations are 9,500,851 and 4,095,393. FY2026 is nearly even ($878.7M vs $843.6M).

What industries lead New Jersey and Oklahoma federal awards?

New Jersey’s top industry is pharmaceutical preparation manufacturing. Oklahoma’s is other aircraft parts and auxiliary equipment manufacturing. Those slices sit on $8.1B and $5.5B obligation stocks. They mark the largest grouping in each file, not every award in either state. Award counts are 1,162,765 in New Jersey and 50,460 in Oklahoma.

Are New Jersey vs Oklahoma figures Treasury outlays?

No. SpendingVault uses USAspending.gov obligations. Outlays are cash payments and can lag. The $8.1B and $5.5B stacked totals and FY2026 amounts of $878.7M and $843.6M measure award commitments by place of performance, not Monthly Treasury Statement payments.